FA
ABBV icon

FAI Advisors’s AbbVie ABBV Stock Holding History

FAI Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$629K Buy
2,406
+356
+17% +$91.3K 0.24% 78
2026
Q2 		$516K Sell
2,050
-89
-4% -$19.1K 0.2% 90
2026
Q1 		$465K Buy
2,139
+19
+0.9% +$4.22K 0.21% 92
2025
Q4 		$484K Buy
2,120
+120
+6% +$27.3K 0.21% 84
2025
Q3 		$463K Buy
2,000
+85
+4% +$17.3K 0.21% 90
2025
Q2 		$355K Buy
1,915
+244
+15% +$45.3K 0.17% 98
2025
Q1 		$350K Sell
1,671
-84
-5% -$16.3K 0.19% 91
2024
Q4 		$312K Buy
+1,755
New +$323K 0.14% 112

Other funds holding ABBV

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

FAI Advisors's ABBV Position: Q3 2026 in Review

FAI Advisors increased its AbbVie (ABBV) stake by 17% in Q3 2026, buying an estimated $91.3K and bringing the position to 2,406 shares worth $629K. The position accounts for 0.24% of the portfolio, ranked #78.

FAI Advisors first reported a position in ABBV in Q4 2024 and has held it in 8 quarters since. 2,802 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • FAI Advisors held 2,406 shares of AbbVie worth $629K as of Q3 2026.
  • FAI Advisors bought 356 AbbVie shares in Q3 2026, an estimated $91.3K.
  • AbbVie made up 0.24% of FAI Advisors's portfolio in Q3 2026, its #78 holding.
  • FAI Advisors first reported a position in AbbVie in Q4 2024 and has held it in 8 quarters since.
  • 2,802 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on FAI Advisors's 13F filing for Q3 2026, filed 27 Oct 2026.